LeonaBio, Inc. (LONA)
NASDAQ: LONA · Real-Time Price · USD
10.70
-0.56 (-4.97%)
May 18, 2026, 10:43 AM EDT - Market open
LeonaBio Market Cap
LeonaBio has a market cap or net worth of $100.51 million as of May 18, 2026. Its market cap has increased by 793.58% in one year.
Market Cap
100.51M
Enterprise Value
38.78M
1-Year Change
793.58%
Ranking
Category
Stock Price
$10.70
Market Cap Chart
Since September 18, 2020, LeonaBio's market cap has decreased from $527.32M to $100.51M, a decrease of -80.94%. That is a compound annual growth rate of -25.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 105.77M | 254.28% |
| Dec 31, 2025 | 29.86M | 31.60% |
| Dec 31, 2024 | 22.69M | -75.47% |
| Dec 29, 2023 | 92.47M | -22.89% |
| Dec 30, 2022 | 119.92M | -75.36% |
| Dec 31, 2021 | 486.68M | -56.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NRx Pharmaceuticals | 108.35M |
| Rani Therapeutics Holdings | 107.80M |
| Verrica Pharmaceuticals | 107.71M |
| PepGen | 107.21M |
| Q32 Bio | 106.83M |
| Inovio Pharmaceuticals | 106.52M |
| Cognition Therapeutics | 101.86M |
| Aldeyra Therapeutics | 101.34M |